Development
Genpact Limited
G
$43.13
$1.032.45%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.15B | 1.14B | 1.11B | 1.09B | 1.10B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.15B | 1.14B | 1.11B | 1.09B | 1.10B |
| Cost of Revenue | 738.70M | 732.96M | 715.48M | 719.08M | 708.94M |
| Gross Profit | 407.55M | 402.83M | 390.04M | 370.24M | 393.61M |
| SG&A Expenses | 240.14M | 229.73M | 229.43M | 216.49M | 228.65M |
| Depreciation & Amortization | 7.45M | 7.50M | 8.26M | 8.26M | 9.86M |
| Other Operating Expenses | -51.00K | -91.00K | -89.00K | -413.00K | -27.91M |
| Total Operating Expenses | 986.24M | 970.10M | 953.08M | 943.41M | 919.55M |
| Operating Income | 160.01M | 165.69M | 152.45M | 145.91M | 183.00M |
| Income Before Tax | 158.47M | 154.91M | 150.37M | 138.48M | 123.12M |
| Income Tax Expenses | -132.84M | 37.31M | 34.12M | 32.37M | 33.41M |
| Earnings from Continuing Operations | 291.31M | 117.59M | 116.25M | 106.10M | 89.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 291.31M | 117.59M | 116.25M | 106.10M | 89.71M |
| EBIT | 160.01M | 165.69M | 152.45M | 145.91M | 183.00M |
| EBITDA | 185.21M | 190.09M | 178.08M | 172.24M | 210.76M |
| EPS Basic | 1.61 | 0.65 | 0.63 | 0.58 | 0.49 |
| Normalized Basic EPS | 0.55 | 0.53 | 0.50 | 0.47 | 0.61 |
| EPS Diluted | 1.59 | 0.64 | 0.63 | 0.57 | 0.48 |
| Normalized Diluted EPS | 0.54 | 0.53 | 0.49 | 0.46 | 0.60 |
| Average Basic Shares Outstanding | 180.96M | 181.40M | 183.23M | 183.80M | 183.37M |
| Average Diluted Shares Outstanding | 183.35M | 183.80M | 185.83M | 187.59M | 187.53M |
| Dividend Per Share | 0.14 | 0.14 | 0.14 | 0.14 | 0.13 |
| Payout Ratio | 8.51% | 21.21% | 21.53% | 23.80% | 25.52% |